← All subjects

How we got here · Healthcare

Why does a hospital bill look like that?

Insurance, hospitals, drugs, PBMs

Timeline · newest first

  1. 2022Law

    Inflation Reduction Act — Medicare can negotiate some drugs

    For the first time, Medicare gains limited authority to negotiate prices on selected high-cost drugs, with phased rollouts. Drug pricing becomes a federal political battlefield again.

    albert bourla

  2. 2010Law

    Affordable Care Act

    Expands coverage (exchanges, Medicaid expansion in many states, young adults on parents’ plans) and bans many pre-existing-condition denials. Does not fully rewrite how hospitals and insurers set prices.

    Nuance Coverage expansion ≠ price control. Many Americans still meet the system through employer plans and opaque hospital chargemasters.

  3. 2000s→Market

    PBMs and insurer–pharmacy integration

    Pharmacy benefit managers sit between insurers, pharmacies, and drugmakers. A few large PBMs and insurer groups control huge share of prescription flows — rebates and “spread pricing” become hard for patients to see.

    thomas j wilson

  4. 1990s→Market

    Hospital and insurer consolidation

    Waves of hospital mergers and insurer consolidation leave many metros with few systems. Less local competition often means higher prices for the same procedures.

  5. 1973Law

    HMO Act and managed care

    Federal policy encourages HMOs and managed care as a cost-control answer. Networks, referrals, and utilization review become normal — and so do patient complaints about denials.

  6. 1965Law

    Medicare and Medicaid created

    Public insurance for seniors and low-income Americans becomes permanent. Hospitals and doctors gain large public payers; the private employer system remains the core for working-age adults.

  7. WWII–1950sPolicy

    Employer-sponsored insurance locks in

    Wartime wage controls push firms to compete with benefits. Tax treatment of employer premiums helps make job-tied coverage the American default — unlike most peer countries.

What people disagree about

  • Whether prices are mainly monopoly hospital power, insurance design, drug patents, or “too much care.”
  • How much PBMs save vs. obscure — the same rebate can look like a discount or a kickback depending on who you ask.

Where we are now

A bill is the end of a chain: employer or public payer → insurer/PBM → hospital or pharmacy → drugmaker. Trace that chain before blaming one villain.

Open the Power Index →